TFX three-lens brief
Evidence-based stock research on TFX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 19.0pp over 30 days. · Trading at 92% of its 52-week range — near the top of the band.
- Trading at 92% of its 52-week range — near the top of the band.
- Outperforming SPY by 19.0pp over 30 days.
- P/E of 104 — priced for high growth; little margin of safety.
- Debt-to-equity of 90.3 — balance-sheet-heavy.
TFX closed at $136.56 (-0.07%) as of 2026-04-25. Market cap: $6.04B. P/E (trailing) 104.2. Positives: outperforming SPY by 19.0pp over 30 days.. Concerns: trading at 92% of its 52-week range — near the top of the band.; p/E of 104 — priced for high growth; little margin of safety.. Last quarter: Revenue $569.00M, net income -$714.33M, free cash flow $12.83M.
Why three lenses on TFX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine TFXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/TFX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath TFX brief"></iframe>